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toxicity. However, a short-term, ACE 
inhibitor-associated increase in serum 
creatinine was found to re4 ect successful 
nephroprotection in patients with renal 
insuJ  ciency by a large metaanalysis. 10 
 While research activities in the cardio-
renal syndromes are only beginning to 
grow and consensus de' nitions are only 
being discussed, clinicians may presently 
not be able to stop the vicious cycle of 
declining renal and cardiac function but 
can nevertheless signi' cantly slow down 
its progression. Treating the shared risk 
factors by adequately lowering blood pres-
sure and suJ  ciently blocking the renin –
 angiotensin system as well as by controlling 
diabetes mellitus, treating dyslipidemia, 
and advocating smoking cessation remains 
of pivotal importance. We as clinicians 
need to consider and attempt to use these 
powerful tools in all our CRS patients. 
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 Dysregulated production of nitric oxide 
(NO) is a key event in the development of 
endothelial dysfunction. Endothelial NO 
production by endothelial NO synthase 
(eNOS) is not only paramount for the relax-
ation of vascular smooth muscle and preven-
tion of its excessive proliferation but is also 
important as a deterrent to platelet aggrega-
tion and leukocyte – endothelial adhesion 
and transmigration. 2 ese actions of NO 
underlie its role in the defense against athero-
sclerosis and its complications. Usually, the 
functional uncoupling of eNOS leads to 
reduced NO availability and endothelial dys-
function due to the preferential generation 
of superoxide and peroxynitrite. In addition, 
the human eNOS gene contains multiple 
polymorphic sites, such as single-nucleotide 
polymorphisms, dinucleotide repeats, and a 
variable number of tandem repeats, some of 
which may have functional consequences. 
2 e most commonly detected and investi-
gated polymorphisms are T786C in the pro-
moter region, eNOS4b / 4a in intron 4, 
and G894T (Glu298Asp) in exon 7. Epide-
miologic studies variably link these 
polymorphisms with increased risk for 
atherosclerosis, myocardial infarction, and 
coronary heart disease. 1 2 e multitude of 
polymorphic sites in the gene poses three 
important problems: on the one hand, poly-
morphisms need to be characterized in eth-
nically divergent populations, 1 and on the 
other, each polymorphism has to be evalu-
ated functionally as a harbinger of potential 
diseases (tasks accomplished by a large body 
of studies recently subjected to metaanaly-
sis 2 ); furthermore, for those polymorphisms 
that are found to be clinically meaningful, 
the molecular defect or defects need to be 
identi' ed. 2 e latter task is most diJ  cult, 
especially in considering the function of an 
enzyme as complex as eNOS. 
 Cherney and co-workers 3 (this issue) 
have attempted to accomplish this task by 
focusing on the functional characterization 
of the G894T eNOS polymorphism in a 
selected group of apparently healthy sub-
jects harboring the T allele. 2 e investiga-
tors used  L -arginine infusion as a challenging 
tool and induced changes in renal hemo-
dynamics as readout parameters. While 
 1 Department  of Medicine, Renal Research Institute, 
New York Medical College ,  Valhalla ,  New York ,  USA ; 
 2 Department of Pharmacology, New York Medical 
College ,  95 Grasslands Road, Valhalla ,  New York ,  USA 
 Correspondence: Michael S. Goligorsky, Depart-
ment of Medicine, Renal Research Institute, New 
York Medical College, Valhalla, New York 10595, 
USA. E-mail:  michael_goligorsky@nymc.edu 
 Endothelial nitric oxide synthase: 
from structure to function in one 
aspartic substitution 
 Michael S.  Goligorsky 1 , 2 
 Cherney and co-workers examine the functional phenotype of the 
G894T eNOS polymorphism in a selected group of apparently healthy 
subjects. The investigators used  L -arginine infusion and induced 
changes in renal hemodynamics. While  L -arginine increased effective 
plasma flow and glomerular filtration rate in GG subjects, these 
responses were blunted in GT / TT subjects, suggesting that either the 
G894T polymorphism impairs eNOS function, or GG subjects exhibit 
augmented eNOS responsiveness to  L -arginine. The complexity of this 
seemingly straightforward conclusion deserves elaboration. 
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 L -arginine resulted in a robust increase in 
eM ective plasma 4 ow and glomerular ' ltra-
tion rate in GG subjects, these responses 
were blunted in GT / TT subjects, suggesting 
that either the G894T (Glu298Asp) poly-
morphism impairs eNOS function or GG 
subjects exhibit augmented eNOS respon-
siveness to  L -arginine. 2 e complexity of 
this seemingly straightforward conclusion 
deserves some elaboration. 
 An  L -arginine-induced increase in NO 
production by the endothelial cells was 
' rst demonstrated by Tsukahara  et al. 4 
with the use of an NO-selective electro-
chemical detection. Considering the fact 
that the  K m of eNOS for  L -arginine is 
around 3   mol / l, the plasma  L -arginine 
level is about 100   mol / l, and the cellular 
 L -arginine concentration is even several-
fold higher, this response has been termed 
the  ‘ L -arginine paradox ’. 2 e reasons for 
this unexpected behavior lie within the 
enzyme itself and its microenvironment. 
 eNOS consists of a C-terminal reductase 
domain and an N-terminal oxygenase 
domain and is homodimerized through 
Cys99-Cys94 motifs on each monomer, 
coordinated via zinc. Cys99 also participates 
in BH 4 and  L -arginine binding. 2 e transfer 
of electrons from NADPH, FAD, and FMN 
in the reductase domain of one monomer 
continues toward the heme domain of the 
other ( Figure 1 ) and is facilitated by the cal-
cium-bound calmodulin. 2 e ferric heme 
moiety accepts electrons to perform two-
step catalysis: hydroxylation of  L -arginine to 
generate  N -hydroxy- L -arginine and its oxi-
dation to  L -citrulline and NO. 5 Several 
phosphory lation sites are critical for eNOS 
function. Phosphorylation at Ser633 and 
Ser1177 activates the enzyme, whereas 
phosphory lation of 2 r495 is inhibitory. 6 
Uncoupling of O 2 reduction from NO syn-
thesis does not require monomerization of 
the enzyme; rather, it occurs as a result of the 
substrate and BH 4 de' ciency, resulting in 
the preferential generation of superoxide 
over NO, enhanced generation of peroxy-
nitrite with further depletion of BH 4 (oxida-
tion to BH 3 ), and reduction of NO. 
 On the basis of this brief summary of 
eNOS structure – function, the potential 
consequences of infusion of  L -arginine, 
apart from its serving as a substrate for the 
enzyme, can be envisaged. 
 (1)  Upregulation of arginase II activity 
and expression has been described in vari-
ous cardiovascular diseases accompanied by 
endothelial dysfunction, thus potentially 
leading to a relative  L -arginine de' ciency at 
the vicinity of eNOS harbored in caveolae. 5 
 L -arginine infusion may change its subcel-
lular distribution in close proximity to the 
cationic amino acid transporter-1 channel, 
which is also present in caveolae. 
 (2)  Elevated levels of a product of pro-
tein arginine  N -methyltransferase, asym-
metric dimethyl arginine (ADMA), which 
o: en accompanies endothelial dysfunc-
tion, results in competition with  L -
arginine as a substrate. 2 is balance could 
be shi: ed by  L -arginine infusion. 
 (3)  2 e guanidino nitrogen group in 
 L -arginine possesses radical-scavenging 
activity, thus protecting NO from the 
reaction with superoxide. Hence, admin-
istration of this amino acid may lead to 
the improved scavenging of free oxygen 
radicals in states of oxidative stress. 
 (4)  Cooperativity between  L -arginine and 
BH 4 binding sites may improve the binding 
of the latter to eNOS with the correction of 
its uncoupled state a: er  L -arginine infusion. 
 (5)  Non-substrate actions of the guanidino 
nitrogen group in arginine through activa-
tion of   2 -adrenoreceptor (analogous to 
agmatine) and secondary activation of eNOS 7 
need to be considered. 2 is eM ect is not stereo-
specific; it occurs also in response to  D -
arginine, thus necessitating the use of both 
stereoisomers to distinguish the substrate 
from the non-substrate actions o f  L -arginine. 
 Despite this possible complexity in inter-
preting  L -arginine action, the Ockham ’ s razor 
approach taken by Cherney  et al . 3 oM ers the 
most probable explanation: blunted responses 
to  L -arginine in the G894T (Glu298Asp) 
polymorphism are due to the uncoupling of 
the enzyme. Previous functional molecular 
analysis of the G894T polymorphism has 
brought about controversial ' ndings. On the 
one hand, aspartic substitution at position 
298 results in the appearance of an N-termi-
nal 35-kilodalton and a C-terminal 100-kilo-
dalton cleavage fragment, which was 
attributed to the increased susceptibility to 
proteolysis. 8 On the other hand, this ' nding 
was attributed to acidic hydrolysis during 
sample preparation, and analysis of eNOS 
activity of Glu298Asp showed that it was 
similar to that of the wild-type enzyme. 9 Nev-
ertheless, it was acknowledged that a 100-
kilodalton fragment may exhibit the reductase 
activity and generate superoxide, but not NO. 
2 e follow-up study of the Glu298Asp variant 
showed that its caveolar sequestration was 
reduced under basal conditions, and, more 
importantly, shear stress caused impaired dis-
sociation from caveolin-1, thus potentially 
explaining reduced NO generation. 10 2 ree-
dimensional molecular modeling of eNOS 
suggested that FMN is inserted into a wide 
channel within the oxygenase domain proxi-
mal to heme, enabling eJ  cient electron trans-
fer. 11 Recent modeling studies suggest that 
docking of the FMN module to the oxygenase 
domain would be shi: ed in the case of Glu-
298Asp, resulting in less eJ  cient alignment 














 Figure 1  |  Schematic presentation of eNOS homodimer indicating the flow of electrons (red 
arrows) from NADPH to the heme iron in the process of generation of NO and citrulline. When 
this flow of electrons is disrupted, the heme-bound dioxygen is released as superoxide anion. 
ADMA, asymmetric dimethyl arginine, CM, calmodulin. Adapted from ref. 5. 
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wild-type eNOS, and in increased release of 
heme-bound dioxygen as a superoxide anion 
(SS Gross, personal communication). 
 In conclusion, the study by Cherney  et al. , 3 
though not completely resolving the mystery 
of Glu298Asp substitution in eNOS, does pro-
mote the idea of the functional liability of this 
polymorphism. However, one should recog-
nize that a multitude of interpretations is bur-
ied within the super' cial simplicity of the 
 L -arginine challenge test. Future studies should 
address at least some of them by also using 
 D -arginine infusion (to rule out non-substrate 
actions) and performing western blotting of 
eNOS using N and C terminus-recognizing 
antibodies (to examine tissues for the presence 
of eNOS fragments). In the future, all these 
eM orts may become incorporated into indi-
vidualized preventive medicine. 
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of HIF signaling appears to be a two-
edged sword. Whereas proangiogenic and 
cytoprotective eM ects of HIF-dependent 
mediators under certain chronic renal 
disease conditions may have a protective 
function, 3 HIF eM ectors can be harmful; 
direct regulation of ' brinogenic factors, 
synergetic interaction with the pro' brotic 
transforming growth factor-  (TGF-  ), 
and the potential role of TGF-  in epithe-
lial-to-mesenchymal transition and in 
inflammation have the potential to 
perpetuate chronic kidney disease 
progression. 4 
 2 erefore, it is important to decode pre-
sumably cell type- and context-dependent 
HIF-related biological functions to 
develop therapeutic interventions that 
improve tissue oxygenation and halt the 
progression of ' brosis. Kojima  et al. 5 (this 
issue) demonstrate encouraging func-
tional interactions of the HIF pathway 
with other signaling pathways that are rel-
evant for basal cell functions such as pro-
tein-translation control or cell survival 
and apoptosis. 
 2 e approaches that the authors used to 
show the cross-links between HIF signal-
ing and other major intracellular signaling 
 Metallothionein: a new soldier 
in the fight against chronic renal 
hypoxia? 
 Reinhard  Bauer 1 
 Sustained hypoxia appears to be an early and pivotal condition in the 
pathogenesis of chronic kidney disease, and may induce a number of 
adaptive / protective or harmful cellular responses. Kojima and 
colleagues found an upregulation of metallothioneins (MTs) among 
dozens of altered expression patterns. They demonstrated the 
astonishing properties of MTs within major intracellular signaling 
pathways beyond their notorious functions in heavy metal metabolism, 
detoxification, and ROS scavenging — HRE stimulation during normoxia 
and hypoxia together with ERK phosphorylation and mTOR activation. 
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 A decline in renal oxygenation can pre-
cede matrix accumulation in chronic kid-
ney diseases, suggesting that sustained 
ischemic hypoxia above the necrotic 
threshold may initiate and promote tubu-
lointerstitial ' brosis. 2 is can cause pro-
gressive renal dysfunction and tissue 
destruction, the ' nal common pathway 
leading to end-stage renal failure. 1 Con-
sequently, hypoxia-inducible transcrip-
tion factors (HIFs), the master switches of 
oxygen-dependent gene regulation, 
appear to play a crucial role in the dynam-
ics and fate of poorly oxygenated renal 
tissue. In contrast to acute renal ischemia –
 reperfusion injuries, wherein HIF target 
genes are mainly involved in cellular 
mechanisms that improve outcome by 
increased hypoxia tolerance or enhanced 
oxygen availability, 2 long-term activation 
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